Statement of Share Capital of Sartorius Stedim Biotech SA as of January 31, 2026

Sartorius Stedim Biotech SA, located in Aubagne, France, has published a statement regarding its share capital as of January 31, 2026. According to this statement, the total number of shares comprising the share capital is 97,330,405. Theoretical voting rights, including treasury shares held by the company, amount to 164,793,720, while net voting rights total 164,753,345. This information has been disclosed in accordance with Article L 233-8-II of the French Commercial Code and Article 223-6 of the General Regulation of the French Financial Markets Authority (AMF).